685 related articles for article (PubMed ID: 25988916)
1. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
Wallace ZS; Deshpande V; Mattoo H; Mahajan VS; Kulikova M; Pillai S; Stone JH
Arthritis Rheumatol; 2015 Sep; 67(9):2466-75. PubMed ID: 25988916
[TBL] [Abstract][Full Text] [Related]
2. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
3. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.
Wallace ZS; Mattoo H; Carruthers M; Mahajan VS; Della Torre E; Lee H; Kulikova M; Deshpande V; Pillai S; Stone JH
Ann Rheum Dis; 2015 Jan; 74(1):190-5. PubMed ID: 24817416
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
5. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
[TBL] [Abstract][Full Text] [Related]
6. Predictors of disease relapse in IgG4-related disease following rituximab.
Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
[TBL] [Abstract][Full Text] [Related]
7. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India.
Gupta N; Mathew J; Mohan H; Chowdhury SD; Kurien RT; Christopher DJ; Thangakunam B; Alexander M; Sivadasan A; Tamilarasi V; Valson AT; Gowri M; Kabeerdoss J; Danda D
Rheumatol Int; 2018 Feb; 38(2):203-209. PubMed ID: 28550399
[TBL] [Abstract][Full Text] [Related]
8. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease.
Akiyama M; Suzuki K; Yamaoka K; Yasuoka H; Takeshita M; Kaneko Y; Kondo H; Kassai Y; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Rheumatol; 2015 Sep; 67(9):2476-81. PubMed ID: 25989153
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for IgG4-related disease: a prospective, open-label trial.
Carruthers MN; Topazian MD; Khosroshahi A; Witzig TE; Wallace ZS; Hart PA; Deshpande V; Smyrk TC; Chari S; Stone JH
Ann Rheum Dis; 2015 Jun; 74(6):1171-7. PubMed ID: 25667206
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
[TBL] [Abstract][Full Text] [Related]
12. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease.
Kubo S; Nakayamada S; Zhao J; Yoshikawa M; Miyazaki Y; Nawata A; Hirata S; Nakano K; Saito K; Tanaka Y
Rheumatology (Oxford); 2018 Mar; 57(3):514-524. PubMed ID: 29253269
[TBL] [Abstract][Full Text] [Related]
13. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.
Akiyama M; Yasuoka H; Yamaoka K; Suzuki K; Kaneko Y; Kondo H; Kassai Y; Koga K; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 Jul; 18():167. PubMed ID: 27411315
[TBL] [Abstract][Full Text] [Related]
14. The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls.
Arora K; Rivera M; Ting DT; Deshpande V
Histopathology; 2019 Apr; 74(5):688-698. PubMed ID: 30408214
[TBL] [Abstract][Full Text] [Related]
15. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial.
Wu Q; Chang J; Chen H; Chen Y; Yang H; Fei Y; Zhang P; Zeng X; Zhang F; Zhang W
Int J Rheum Dis; 2017 May; 20(5):639-646. PubMed ID: 28556584
[TBL] [Abstract][Full Text] [Related]
16. Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers.
Lanzillotta M; Campochiaro C; Trimarchi M; Arrigoni G; Gerevini S; Milani R; Bozzolo E; Biafora M; Venturini E; Cicalese MP; Stone JH; Sabbadini MG; Della-Torre E
Mod Rheumatol; 2017 Jul; 27(4):638-645. PubMed ID: 27622319
[TBL] [Abstract][Full Text] [Related]
17. Clinical characterization of 52 patients with immunoglobulin G4-related disease in a single tertiary center in Japan: Special reference to lung disease in thoracic high-resolution computed tomography.
Saraya T; Ohkuma K; Fujiwara M; Miyaoka C; Wada S; Watanabe T; Mikura S; Inoue M; Oda M; Sada M; Ogawa Y; Honda K; Tamura M; Yokoyama T; Kurai D; Ishii H; Takizawa H
Respir Med; 2017 Nov; 132():62-67. PubMed ID: 29229107
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serologic parameters and disease activity of IgG4-related disease: Differences between patients with normal and elevated serum IgG4 concentrations.
Kwon OC; Park MC; Kim YG
Front Immunol; 2022; 13():1020459. PubMed ID: 36311699
[TBL] [Abstract][Full Text] [Related]
19. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease.
Tartakover Matalon S; Rabinowicz N; Carmi O; Zitman-Gal T; Drucker L; Levy Y
Isr Med Assoc J; 2024 Jun; 26(6):369-375. PubMed ID: 38884310
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Approach to the Complexity of IgG4-Related Disease.
Stone JH; Brito-Zerón P; Bosch X; Ramos-Casals M
Mayo Clin Proc; 2015 Jul; 90(7):927-39. PubMed ID: 26141331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
